Transthyretin-directed RNA Interaction [EPC] - N0000193849
Pharmacologic Class Information
Pharmacologic Code | N0000193849 |
Pharmacologic Name | Transthyretin-directed RNA Interaction |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with Transthyretin-directed RNA Interaction
The table contains 3 products whose active ingredient are classified under the same pharmacologic class Transthyretin-directed RNA Interaction [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
71336-1000 | Onpattro | Non-Proprietary Name: Patisiran | Injection, Lipid Complex | Intravenous | Alnylam Pharmaceuticals, Inc. | ACTIVE | |
71336-1003 | Amvuttra | Non-Proprietary Name: Vutrisiran | Injection | Subcutaneous | Alnylam Pharmaceuticals, Inc. | ACTIVE | |
72126-007 | Tegsedi | Non-Proprietary Name: Inotersen | Injection, Solution | Subcutaneous | Akcea Therapeutics, Inc. | ACTIVE |